Cargando…

Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial

BACKGROUND: Direct oral anticoagulants (DOACs) pose a great challenge for physicians in life-threatening bleeding events. The aim of this study was to test the efficacy of reversing the DOAC rivaroxaban using four-factor PCC (prothrombin complex concentrate), a non-specific reversing agent. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schenk, Bettina, Goerke, Stephanie, Beer, Ronny, Helbok, Raimund, Fries, Dietmar, Bachler, Mirjam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763793/ https://www.ncbi.nlm.nih.gov/pubmed/29344007 http://dx.doi.org/10.1186/s12959-017-0158-9

Ejemplares similares

Reversal of rivaroxaban anticoagulant effect by prothrombin complex concentrates: which dose is sufficient to restore normal thrombin generation?
por: Giffard-Quillon, Lorine, et al.
Publicado: (2020)

Use of four‐factor prothrombin complex concentrate for the mitigation of rivaroxaban‐induced bleeding in an emergent coronary artery bypass graft
por: Liu, Michael, et al.
Publicado: (2017)

Thrombin Generation Capacity of Prothrombin Complex Concentrate in an In Vitro Dilutional Model
por: Grottke, Oliver, et al.
Publicado: (2013)

Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products
por: Castillo, Renee, et al.
Publicado: (2020)

Characterization of thrombin derived from human recombinant prothrombin
por: Lövgren, Ann, et al.
Publicado: (2015)

Three- versus four-factor prothrombin complex concentrate for the reversal of warfarin-induced bleeding
por: Holt, Tara, et al.
Publicado: (2018)

Prothrombin time is predictive of low plasma prothrombin concentration and clinical outcome in patients with trauma hemorrhage: analyses of prospective observational cohort studies
por: Balendran, Clare A., et al.
Publicado: (2017)

Correction to: Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products
por: Castillo, Renee, et al.
Publicado: (2020)

Therapeutic monitoring of rivaroxaban in dogs using thromboelastography and prothrombin time
por: Bae, Junwoo, et al.
Publicado: (2019)

Acquired deficiency of prothrombin complex coagulation factors in major bleeding is a therapeutic indication of 4‐factor prothrombin complex concentrates
por: Wiedermann, Christian J.
Publicado: (2020)

Four-factor prothrombin complex concentrate (Beriplex® P/N) is superior to three-factor prothrombin complex concentrate for reversal of coumarin anticoagulation
por: Herzog, E, et al.
Publicado: (2015)

Factors That Determine the Prothrombin Time in Patients With Atrial Fibrillation Receiving Rivaroxaban
por: Huang, Jen-Hung, et al.
Publicado: (2018)

Ex vivo reversal of effects of rivaroxaban evaluated using thromboelastometry and thrombin generation assay
por: Schenk, B., et al.
Publicado: (2016)

Impaired platelet‐dependent thrombin generation associated with thrombocytopenia is improved by prothrombin complex concentrates in vitro
por: Chowdary, Pratima, et al.
Publicado: (2020)

STUDIES ON BLOOD COAGULATION : I. THE RÔLE OF PROTHROMBIN AND OF PLATELETS IN THE FORMATION OF THROMBIN
por: Eagle, Harry
Publicado: (1935)

Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosis
por: Kremers, Romy M. W., et al.
Publicado: (2017)

PROTHROMBIN COMPLEX CONCENTRATE  IN EMERGENCY DEPARTMENT
por: Nesek Adam, Višnja, et al.
Publicado: (2022)

Prothrombin complex concentrate in the management of major bleeding induced by oral anticoagulant therapy
por: AlSheef, Mohammed, et al.
Publicado: (2022)

Comparison of prothrombin complex concentrate and fresh frozen plasma on thrombin generation and hemorrhage in experimental dilutional coagulopathy
por: Dickneite, G, et al.
Publicado: (2008)

Andexanet versus prothrombin complex concentrates: Differences in reversal of factor Xa inhibitors in in vitro thrombin generation
por: Lu, Genmin, et al.
Publicado: (2020)

Four‐factor prothrombin complex concentrate reverses apixaban‐associated bleeding in a rabbit model of acute hemorrhage
por: Herzog, E., et al.
Publicado: (2015)

Four-factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors versus Warfarin in Life-threatening Bleeding
por: Rech, Megan A., et al.
Publicado: (2021)

PROTHROMBIN DEFICIENCY THE CAUSE OF BLEEDING IN BILE FISTULA DOGS
por: Hawkins, W. B., et al.
Publicado: (1936)

Preclinical evaluation of point‐of‐care prothrombin time as a biomarker test to guide prothrombin replacement therapy in coagulopathic bleeding
por: Balendran, Clare A., et al.
Publicado: (2017)

Prothrombin complex concentrates in warfarin anticoagulation reversal
por: Costa-Lima, Carolina, et al.
Publicado: (2012)

Prothrombin Complex Concentrates Only After Thromboelastography
por: Muggleton, Ellis, et al.
Publicado: (2019)

The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review
por: Hoffman, Maureane, et al.
Publicado: (2018)

Effectiveness of prothrombin complex concentrate for the treatment of bleeding: A systematic review and meta‐analysis
por: van den Brink, Daan P., et al.
Publicado: (2020)

Reversing direct factor Xa or thrombin inhibitors: Factor V addition to prothrombin complex concentrate is beneficial in vitro
por: Brinkman, Herm Jan M., et al.
Publicado: (2022)

Enhancing the Quality of Rivaroxaban Exposure Estimates Using Prothrombin Time in the Absence of Pharmacokinetic Sampling
por: Solms, Alexander, et al.
Publicado: (2019)

PROTHROMBIN DEFICIENCY AND THE BLEEDING TENDENCY IN LIVER INJURY (CHLOROFORM INTOXICATION)
por: Smith, H. P., et al.
Publicado: (1937)

The Two-Stage “Prothrombin” Assay in Study of Bleeding and Clotting Disorders
por: Ferguson, John H., et al.
Publicado: (1955)

A case of congenital prothrombin deficiency with two concurrent mutations in the prothrombin gene
por: Mansory, Eman M., et al.
Publicado: (2021)

Four-factor prothrombin complex concentrate (Beriplex® P/N) mediated reversal of apixaban-induced bleeding in a rabbit model
por: Herzog, E, et al.
Publicado: (2015)

Reversibility of Apixaban Anticoagulation with a Four‐Factor Prothrombin Complex Concentrate in Healthy Volunteers
por: Nagalla, S, et al.
Publicado: (2016)

Prothrombin complex concentrate mitigates diffuse bleeding after cardiopulmonary bypass in a porcine model
por: Kaspereit, F., et al.
Publicado: (2010)

Management of the Bleeding Patient Receiving New Oral Anticoagulants: A Role for Prothrombin Complex Concentrates
por: Baumann Kreuziger, Lisa M., et al.
Publicado: (2014)

Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery
por: Cappabianca, Giangiuseppe, et al.
Publicado: (2016)

Efficacy and safety of activated prothrombin complex concentrate for the reversal of vitamin K antagonist major bleeding
por: Sheikh-Taha, Marwan, et al.
Publicado: (2022)

Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding
por: Go, Alan S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bpoh1tu8r08bagu9tpkcemg3an